Figure 2.

Absolute mortality arising from 1‐year deferral of therapy in a low‐risk patient (90% survival if treated with all three classes of drug). The vertical axis represents the proportion of patients alive at 1 year. The grey bar shows the 10% of patients who will die even if treated with all three drug classes. The orange bar shows the additional 3.0% who will die before 1 year if an aldosterone antagonist (AA) is deferred. The green bar shows the further additional 4.8% who will die before 1 year if a beta‐blocker (BB) is deferred. The blue bar shows the additional 4.4% who will die before 1 year if an angiotensin‐converting enzyme inhibitor (ACEi) is deferred. In total, deferral of all three classes of therapy carries a 12.2% risk for death before 1 year, even for a low‐risk patient.